Log in
Enquire now
‌

US Patent 11673953 DLL3 targeting chimeric antigen receptors and binding agents

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116739530
Date of Patent
June 13, 2023
0
Patent Application Number
168028220
Date Filed
February 27, 2020
0
Patent Citations
‌
US Patent 8486693 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
0
‌
US Patent 7709226 Method of humanizing antibodies by matching canonical structure types CDRs
0
‌
US Patent 7741465 Chimeric receptor genes and cells transformed therewith
0
‌
US Patent 7087409 Humanization of murine antibody
0
‌
US Patent 7527791 Humanized anti-TGF-beta antibodies
0
Patent Primary Examiner
‌
Hong Sang
0
CPC Code
‌
C07K 16/2887
0
‌
C07K 2317/24
0
‌
C07K 2317/565
0
‌
C07K 2317/622
0
‌
C07K 2319/70
0
‌
C07K 2319/03
0
‌
C07K 2319/33
0
‌
C07K 16/28
0
...

Provided herein are DLL3 binding agents and chimeric antigen receptors (CARs) comprising a DLL3 binding molecule that specifically binds to DLL3; and immune cells comprising these DLL3-specific CARs, e.g., CAR-T cells. Also provided are methods of making and using DLL3-specific CARs, and immune cells comprising DLL3-specific CARs.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11673953 DLL3 targeting chimeric antigen receptors and binding agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.